Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Corus Pharma
About
Corus Pharma Inc., a Seatle-based biotech and specialty drug company focused on respiratory and infectious diseases.
- 501 - 1000
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $65M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 501 - 1000
- Operating Status
- Close
Corus Pharma is a biotech and specialty drug company that focuses on respiratory and infectious diseases. In other words, it is a development stage biopharmaceutical company that focuses on the development and commercialization of novel applications and formulations of known therapeutics to treat severe respiratory diseases. The products of the company are Corus 1020 and 1030. Corus 1020 is designed to treat respiratory infections in cystic fibrosis patients, using an inhalable form of an antibiotic called aztreonam. Corus 1030 is inhaled lidocaine for the treatment of patients suffering from the severe persistent forms of asthma.Corus Pharma is a U.S.-based company that was founded in 2001 and the company was acquired by Gilead Sciences on October 22, 2006.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 13, 2004 | Series C | $65M | 2 |
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
Pacific Rim Ventures
|
— | Series C |
